Zeria Pharmaceutical Co., Ltd. (TYO:4559)
1,898.00
-53.00 (-2.72%)
Oct 2, 2026, 3:30 PM JST
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 83.66 billion as of October 2, 2026. Its market cap has decreased by -4.43% in one year.
Market Cap
83.66B
Enterprise Value
92.66B
Revenue
91.12B
Ranking
n/a
PE Ratio
10.17
Stock Price
1,898.00
ChartMarket Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 83.66B, an increase of 43.96%. That is a compound annual growth rate of 1.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 83.66B | -9.58% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 183.82B |
| Towa Pharmaceutical | 175.74B |
| Kissei Pharmaceutical | 153.09B |
| Kaken Pharmaceutical | 142.95B |
| Mochida Pharmaceutical | 108.96B |
| KYORIN Pharmaceutical | 61.18B |
| ASKA Pharmaceutical Holdings | 57.64B |
| Fuji Pharma | 44.93B |